lyell.com - LYEL Income before deduction of interest, taxes and amortization

Graphic logo of Lyell (LYEL)

High patent barriers and stringent FDA oversight protect the market positions of Lyell Immunopharma (LYEL). The absolute EBITDA volume on this precise GURU.Markets chart visualizes these complexities, where 0.00 serves as the base parameter value. The robotization of molecular design accelerates drug synthesis, while strict compliance with environmental standards in clean zones ensures the safety of biohazardous waste.

Profit before payment of interest, taxes and amortization: Lyell Immunopharma (LYEL) for 11/23/2025 - 11/17/2026

Lyell - analytical breakdowns and key metrics (LYEL)

- market value and analyst target forecast:
Analysis of all company metrics:lyell.com - LYEL
Mass-produced product of Lyell Immunopharma, Inc.

Distinguishing market noise from actual operational model efficiency is critical for long-term asset screening. This indicator measures net cash flow from core operations before depreciation and interest, which, under neutral US geopolitics, allows for an assessment of the real scalability of biotech developments for Lyell Immunopharma (LYEL) by analyzing monthly EBITDA dynamics.

Competitors of Lyell Immunopharma (LYEL)

ImmunityBio (IBRX) - Profit before interest, taxes and amortization|IMCR: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization JANX (Janux Therapeutics, Inc.)|RCUS: Operating profit EBITDA|ZYME - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization tangotx.com|Operating profit before deduction of amortization iovance.com (IOVA)|Profit before payment of interest, taxes and amortization Immatics NV (IMTX)|Operating profit before deduction of amortization Xencor Corp XNCR|Compass Therapeutics Inc - Operating profit before deduction of amortization|Operating profit EBITDA Replimune Inc. REPL|IPHA - Profit before payment of interest, taxes and amortization|PYXS (Pyxis Oncology) - Operating profit before amortization|cgen.com (CGEN) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization IO Biotech Corp (IOBT)|Operating profit before deduction of amortization STRO|INKT - Operating profit before depreciation charges|Operating profit before deduction of amortization HOWL (Werewolf Therapeutics)|Company profit before taxes, interest and amortization IMMX|Operating profit EBITDA ALXO (ALX Oncology)|cuebiopharma.com (CUE) - Profit before interest, taxes and amortization|PDS Biotechnology Corp - Operating profit EBITDA|Profit before interest, taxes and amortization Sonnet BioTherapeutics Holdings|MAIA Biotechnology (MAIA) - Profit before payment of interest, taxes and amortization|Liminatus Pharma - Income before deduction of interest, taxes and amortization|LVTX (Lava Tx) - Operating profit EBITDA|Operating profit EBITDA NextCure Inc|Profit before payment of interest, taxes and amortization leaptx.com (LPTX)|INTS: Profit before deduction of interest, taxes, depreciation and amortization|Sensei Biotherapeutics, Inc. - Operating profit before deduction of amortization|Theriva Biologics (TOVX) - Profit before interest, taxes and amortization|gritstonebio.com - Operating profit EBITDA|KA (Kineta) - Operating profit before amortization|NEXI: Operating profit EBITDA|Turnstone Biologics Corporation (TSBX) - Operating profit EBITDA|VCNX (vaccinex.com) - Operating profit EBITDA|HARP: Income before deduction of interest, taxes and amortization